Rankings
▼
Calendar
VERA Q4 2020 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
VERA
Vera Therapeutics, Inc.
$3B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$43M
Net Income
-$43M
EPS (Diluted)
$-2.09
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$27M
Free Cash Flow
-$27M
Stock-Based Comp.
$143,000
Balance Sheet
Total Assets
$55M
Total Liabilities
$144M
Stockholders' Equity
-$89M
Cash & Equivalents
$54M
← FY 2020
All Quarters
Q1 2021 →